REVANCE THERAPEUTICS INC's ticker is RVNC and the CUSIP is 761330109. A total of 166 filers reported holding REVANCE THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is 0.94 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2022 | $1,744,000 | -91.1% | 64,590 | -95.4% | 0.22% | -88.9% |
Q2 2022 | $19,598,000 | -29.4% | 1,418,088 | -0.4% | 1.97% | +6.3% |
Q1 2022 | $27,757,000 | +17.3% | 1,423,425 | -1.8% | 1.85% | +43.8% |
Q4 2021 | $23,661,000 | +941.9% | 1,449,835 | +1678.9% | 1.29% | +1214.3% |
Q3 2021 | $2,271,000 | – | 81,500 | – | 0.10% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
NovaQuest Capital Management, L.L.C. | 1,558,426 | $48,000,000 | 65.50% |
Essex Woodlands Management, Inc. | 3,842,047 | $118,335,000 | 25.90% |
Rhenman & Partners Asset Management AB | 203,181 | $6,258,000 | 0.77% |
EAM Global Investors LLC | 44,898 | $1,383,000 | 0.72% |
Fosun International Ltd | 319,313 | $9,835,000 | 0.62% |
EAM Investors, LLC | 113,096 | $3,483,000 | 0.58% |
ArrowMark Colorado Holdings LLC | 1,735,699 | $53,460,000 | 0.53% |
Perceptive Advisors | 618,957 | $19,064,000 | 0.53% |
ESSEX INVESTMENT MANAGEMENT CO LLC | 111,360 | $3,430,000 | 0.45% |
Schonfeld Strategic Advisors LLC | 83,700 | $2,578,000 | 0.19% |